ELVN vs. MP
ELVN (Enliven Therapeutics Inc.) and MP (MP Materials Corp.) are both stocks. ELVN operates in Biotechnology (Healthcare), while MP operates in Other Industrial Metals & Mining (Basic Materials). Over the past 5 years, ELVN returned 2.00%/yr vs 16.72%/yr for MP. At a 0.19 correlation, their price movements are largely independent.
Performance
ELVN vs. MP - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ELVN achieves a 133.96% return, which is significantly higher than MP's 35.69% return.
ELVN
- 1D
- 1.44%
- 1M
- -13.41%
- YTD
- 133.96%
- 6M
- 71.57%
- 1Y
- 64.82%
- 3Y*
- 18.69%
- 5Y*
- 2.00%
- 10Y*
- —
MP
- 1D
- -5.11%
- 1M
- 3.55%
- YTD
- 35.69%
- 6M
- 16.76%
- 1Y
- 211.59%
- 3Y*
- 45.90%
- 5Y*
- 16.72%
- 10Y*
- —
ELVN vs. MP - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
ELVN Enliven Therapeutics Inc. | 133.96% | -31.56% | 62.57% | -15.40% | 81.78% | -89.80% | -46.10% |
MP MP Materials Corp. | 35.69% | 223.85% | -21.41% | -18.25% | -46.54% | 41.19% | 221.70% |
Correlation
The correlation between ELVN and MP is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.09 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.19 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.18 |
Correlation (All Time) Calculated using the full available price history since Jun 23, 2020 | 0.19 |
The correlation between ELVN and MP shifts across timeframes, from 0.09 (1 year) to 0.19 (3 years), reflecting how their relationship changes across market environments.
Fundamentals
ELVN:
-$1.69
MP:
-$0.53
ELVN:
$0.00
MP:
$305.30M
ELVN:
-$46.00K
MP:
$25.30M
ELVN:
-$110.65M
MP:
$1.52M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ELVN vs. MP — Risk / Return Rank
ELVN
MP
ELVN vs. MP - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Enliven Therapeutics Inc. (ELVN) and MP Materials Corp. (MP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ELVN | MP | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.47 | ||
| Sortino ratioReturn per unit of downside risk | -1.23 | ||
| Omega ratioGain probability vs. loss probability | 1.22 | 1.36 | -0.15 |
| Calmar ratioReturn relative to maximum drawdown | 1.77 | 3.96 | -2.19 |
| Martin ratioReturn relative to average drawdown | 4.61 | 6.77 | -2.15 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| ELVN | MP | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.80 | 2.27 | -1.47 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.02 | 0.24 | -0.22 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.09 | 0.53 | -0.62 |
Drawdowns
ELVN vs. MP - Drawdown Comparison
The maximum ELVN drawdown since its inception was -98.20%, which is greater than MP's maximum drawdown of -81.99%. Use the drawdown chart below to compare losses from any high point for ELVN and MP.
Loading charts...
Drawdown Indicators
| ELVN | MP | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.20% | -81.99% | -16.21% |
Max Drawdown (1Y)Largest decline over 1 year | -36.84% | -53.79% | +16.95% |
Max Drawdown (3Y)Largest decline over 3 years | -56.05% | -59.47% | +3.42% |
Max Drawdown (5Y)Largest decline over 5 years | -89.05% | -81.99% | -7.06% |
Current DrawdownCurrent decline from peak | -83.58% | -30.51% | -53.07% |
Average DrawdownAverage peak-to-trough decline | -84.22% | -42.63% | -41.59% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 14.09% | 31.40% | -17.31% |
Volatility
ELVN vs. MP - Volatility Comparison
The current volatility for Enliven Therapeutics Inc. (ELVN) is 14.50%, while MP Materials Corp. (MP) has a volatility of 21.38%. This indicates that ELVN experiences smaller price fluctuations and is considered to be less risky than MP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ELVN | MP | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 14.50% | 21.38% | -6.88% |
Volatility (6M)Calculated over the trailing 6-month period | 60.61% | 50.40% | +10.21% |
Volatility (1Y)Calculated over the trailing 1-year period | 82.50% | 93.94% | -11.44% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 85.81% | 69.57% | +16.24% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 87.95% | 72.60% | +15.35% |
Dividends
ELVN vs. MP - Dividend Comparison
Neither ELVN nor MP has paid dividends to shareholders.
Financials
ELVN vs. MP - Financials Comparison
This section allows you to compare key financial metrics between Enliven Therapeutics Inc. and MP Materials Corp.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ELVN and MP have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
MP has higher volatility (21.38%) compared to ELVN (14.50%). In terms of maximum drawdown, ELVN dropped -98.20% vs MP's -81.99%.
MP currently has the higher Sharpe Ratio (2.27 vs 0.80), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ELVN and MP
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer